Incidental chronic lymphocytic leukemia diagnosed following radical prostatectomy for prostate cancer: A case report.

Autor:	Tlili G; Department of Urology, Sahloul Hospital, Sousse, Tunisia., Ammar H; Department of Gastrointestinal Surgery, Sahloul Hospital, Sousse, Tunisia., Majdoub W; Department of Anatomopathology, Sahloul Hospital, Sousse, Tunisia., Dziri S; Department of Nephrology, Sahloul Hospital, Sousse, Tunisia., Farhat W; Department of Gastrointestinal Surgery, Sahloul Hospital, Sousse, Tunisia., Acacha E; Department of Urology, Sahloul Hospital, Sousse, Tunisia., Rguez A; Department of Gastrointestinal Surgery, Sahloul Hospital, Sousse, Tunisia., Ben Ahmed K; Department of Urology, Sahloul Hospital, Sousse, Tunisia., Azzabi A; Department of Nephrology, Sahloul Hospital, Sousse, Tunisia., Jaidane M; Department of Urology, Sahloul Hospital, Sousse, Tunisia.
Jazyk:	angličtina
Zdroj:	Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2021 Jun 25; Vol. 68, pp. 102516. Date of Electronic Publication: 2021 Jun 25 (Print Publication: 2021).
DOI:	10.1016/j.amsu.2021.102516
Abstrakt:	Background: chronic lymphocytic leukemia (CLL) patients have a high risk of occurrence of secondary cancers. This risk is three times higher for all cancers and eight times higher for skin cancer. The coexistence of CLL and adenocarcinoma of the prostate is rare. Case Presentation: We report a case of a66-year-old man who underwent radical prostatectomy for prostate carcinoma. The final histopathological diagnosis of Gleason 7 adenocarcinoma of the prostate with incidental Rai stage I chronic lymphocytic leukemia (CLL) was made. No further investigations or treatment was offered due to the age and low disease stage. At the last follow-up of 12 months, the patient is alive, without disease progression for both lymphoma and prostate, with a PSA value of 0.03 ng/ml. Conclusion: Early detection of lymphoma after radical prostatectomy will allow optimal management. The analysis of this link requires, therefore, additional investigations. Competing Interests: The authors declare that they have no conflict of interest. (© 2021 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu